Carolina Journal by Video - CCCII: Charging Syria $1.1 billion for ties to terrorism | Eastern NC Now

Attorney Kieran Shanahan of Raleigh discusses U.S. District Judge Terrence Boyle’s June decision to award $1.1 billion to victims of terrorism sponsored by Syria.

ENCNow
    Publisher's Note: This post appears here courtesy of the Carolina Journal. Presented in this Carolina Journal video broadcast is Mitch Kokai.

    The Carolina Journal makes a wide sweeping evaluation of the news that most effects us here in North Carolina, and is distilled, here on BCN, for your clear understanding by the electronic means of video broadcast.



    Attorney Kieran Shanahan of Raleigh discusses U.S. District Judge Terrence Boyle’s June decision to award $1.1 billion to victims of terrorism sponsored by Syria. Shanahan discussed the case with Mitch Kokai for Carolina Journal’s “Issues and Insiders.”

    Publisher's note: If you find these video vignettes informative, you can find all of the Carolina Journal TV videos here.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




Two-thirds of North Carolina Voters Are Worried about Crime in Their Neighborhood Carolina Journal, Editorials, Op-Ed & Politics Judge declines to block new federal farm labor wage rule


HbAD0

Latest Op-Ed & Politics

Ozturk's detention became a flashpoint in President Trump's mass deportation campaign.
(RALEIGH) Today, Governor Stein announced he has signed one bill into law.

HbAD1

Mexican equivalent of ICE conducting raids on migrants in Mexico City
“President Trump has always been clear about short-term disruptions as a result of Operation Epic Fury."

HbAD2

ruling leaves congressional districts intact = huge blow to Spanberger
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic
If you are covering Roy Cooper in Greensboro today, please consider the following statement from the Republican National Committee:

HbAD3

 
 
Back to Top